Related Experiment Video
Updated: Jul 15, 2026

Phenotypic and Functional Characterization of Endothelial Colony Forming Cells Derived from Human Umbilical Cord Blood
Published on: April 13, 2012
Endothelial Progenitor Cells for Ischemic Stroke: Update on Basic Research and Application.
Shaohua Liao1,2, Chunxia Luo2, Bingzhen Cao3
1Department of Neurology, People's Liberation Army 152 Hospital, Pingdingshan, Henan 467000, China.
Endothelial progenitor cells (EPCs) show promise for treating ischemic stroke by repairing the neurovascular unit. Combining EPCs with new technologies may improve neurological recovery beyond current thrombolytic therapy limitations.
Area of Science:
- Regenerative Medicine
- Neuroscience
- Vascular Biology
Background:
- Ischemic stroke is a major cause of death and disability globally.
- Current ultra-early thrombolytic therapy has a narrow time window, leaving many patients with neurological deficits.
- Endothelial progenitor cells (EPCs), a type of adult stem cell, offer neurovascular protection.
Purpose of the Study:
- To review basic research and clinical trials on EPCs for ischemic stroke.
- To explore novel therapeutic strategies combining EPCs with emerging technologies.
- To provide insights into future applications of EPCs in ischemic stroke treatment.
Main Methods:
- Literature review of preclinical studies and clinical trials involving EPCs in ischemic stroke.
- Analysis of studies combining EPCs with neurovascular intervention, synthetic particles, cytokines, and cell modification.
- Synthesis of current research to identify future therapeutic directions.
Main Results:
- EPCs demonstrate efficacy in repairing vascular endothelium and its secretory function.
- EPC transplantation supports the recovery of neurological function post-stroke.
- Emerging technologies show potential for enhancing EPC-based therapies.
Conclusions:
- EPCs represent a promising therapeutic avenue for ischemic stroke.
- Combination therapies involving EPCs and advanced technologies may overcome limitations of current treatments.
- Further research is warranted to optimize EPC application for improved patient outcomes.
More Related Videos
08:43Isolation of Endothelial Progenitor Cells from Healthy Volunteers and Their Migratory Potential Influenced by Serum Samples After Cardiac Surgery
Published on: February 14, 2017
07:26Isolation of Endothelial Progenitor Cells from Human Umbilical Cord Blood
Published on: September 14, 2017
Related Concept Videos
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Ischemic Stroke l: Introduction
Ischemic Stroke ll: Pathophysiology
Hemorrhagic Stroke l: Introduction
Hemorrhagic Stroke ll: Pathophysiology